LIXTE BIOTECHNOLOGY HOLDINGS, INC.

NMADReported to SECin USCIK 0001335105Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 6. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 6
Form 4 lines at LIXTE BIOTECHNOLOGY HOLDINGS, INC., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Stazzone PeterChief Financial OfficerAwardnothing paid50,000 sharesJul 2, 2026Stazzone PeterChief Financial Officernothing paidAward · Jul 2Award50,000Jul 2, 2026
Sawyer Jason David—Awardnothing paid40,000 sharesJul 2, 2026Sawyer Jason Davidnothing paidAward · Jul 2Award40,000Jul 2, 2026
Pursglove Geordan GarrettCEO and Chairman of the BoardAwardnothing paid350,000 sharesJul 2, 2026Pursglove Geordan GarrettCEO and Chairman of the Boardnothing paidAward · Jul 2Award350,000Jul 2, 2026
Primus Guy Warren—Awardnothing paid15,000 sharesJul 2, 2026Primus Guy Warrennothing paidAward · Jul 2Award15,000Jul 2, 2026
Holloway Michael Andrew—Awardnothing paid15,000 sharesJul 2, 2026Holloway Michael Andrewnothing paidAward · Jul 2Award15,000Jul 2, 2026